Immucor (BLUD) +3.9% to $20.76 as RBC Capital Markets upgrades the company to 'outperform' from...

|By:, SA News Editor

Immucor (BLUD) +3.9% to $20.76 as RBC Capital Markets upgrades the company to 'outperform' from 'sector perform' and increases the 12-month price target to $25 from $19. Immucor makes products used to screen donated blood.